However, our data showed no statistical difference in the numbers of specific T cells (mainly CD8+ T cells) reactive to different HBV proteins in each disease stage, including R, CHB, LC, HCC, IA, IT, or IC stages. This evidence concerns the gene CD8A and hepatocellular carcinoma.